Literature DB >> 19502292

Possible contribution of the non-proteolytic activation of prorenin to the development of insulin resistance in fructose-fed rats.

Yukiko Nagai1, Atsuhiro Ichihara, Daisuke Nakano, Shoji Kimura, Nicolas Pelisch, Yoshihide Fujisawa, Hirofumi Hitomi, Naohisa Hosomi, Hideyasu Kiyomoto, Masakazu Kohno, Hiroshi Ito, Akira Nishiyama.   

Abstract

Recent studies have shown that blocking non-proteolytically activated prorenin with a decoy peptide for the handle region of the prorenin prosegment (HRP) inhibits the development of microvascular complications in diabetic animals. In the present study, we investigated whether non-proteolytic activation of prorenin contributes to the development of fructose-induced insulin resistance. Rats were fed a standard diet (n = 10), a 60% high fructose diet (n = 16), or a high fructose diet + HRP (0.1 mg kg(-1) day(-1), n = 16) for 10 weeks. Fructose-fed rats showed higher systolic blood pressure (SBP), fasting plasma triglycerides, total cholesterol and insulin levels; which, except for SBP, were suppressed by HRP. The responses of plasma glucose and insulin levels to oral glucose loading were significantly greater in fructose-fed rats than in standard diet-fed rats. The HRP normalized the enhanced responses of plasma glucose and insulin levels that were observed in fructose-fed rats. Moreover, HRP suppressed the enhanced prorenin activation and angiotensin II formation in the soleus muscle of fructose-fed rats. These data suggest that local angiotensin II generation in skeletal muscle, induced by non-proteolytic activation of prorenin, contributes to the development of insulin resistance induced by a high fructose diet.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502292     DOI: 10.1113/expphysiol.2009.048108

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  16 in total

1.  Angiotensin II shifts insulin signaling into vascular remodeling from glucose metabolism in vascular smooth muscle cells.

Authors:  Hirofumi Hitomi; Kumiko Kaifu; Yoshiko Fujita; Tadashi Sofue; Daisuke Nakano; Kumiko Moriwaki; Taiga Hara; Hideyasu Kiyomoto; Masakazu Kohno; Hiroyuki Kobori; Akira Nishiyama
Journal:  Am J Hypertens       Date:  2011-06-30       Impact factor: 2.689

Review 2.  Possible contribution of (pro)renin receptor to development of gestational diabetes mellitus.

Authors:  Kanako Bokuda; Atsuhiro Ichihara
Journal:  World J Diabetes       Date:  2014-12-15

3.  Activation of Renal (Pro)Renin Receptor Contributes to High Fructose-Induced Salt Sensitivity.

Authors:  Chuanming Xu; Aihua Lu; Xiaohan Lu; Linlin Zhang; Hui Fang; Li Zhou; Tianxin Yang
Journal:  Hypertension       Date:  2016-12-19       Impact factor: 10.190

4.  Angiotensin receptor blockade increases pancreatic insulin secretion and decreases glucose intolerance during glucose supplementation in a model of metabolic syndrome.

Authors:  Ruben Rodriguez; Jose A Viscarra; Jacqueline N Minas; Daisuke Nakano; Akira Nishiyama; Rudy M Ortiz
Journal:  Endocrinology       Date:  2012-02-21       Impact factor: 4.736

5.  Chronic AT1 blockade improves hyperglycemia by decreasing adipocyte inflammation and decreasing hepatic PCK1 and G6PC1 expression in obese rats.

Authors:  Ruben Rodriguez; Andrew Y Lee; Jose A Godoy-Lugo; Bridget Martinez; Hiroyuki Ohsaki; Daisuke Nakano; David G Parkes; Akira Nishiyama; José Pablo Vázquez-Medina; Rudy M Ortiz
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-10-18       Impact factor: 4.310

6.  Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats.

Authors:  Ruben Rodriguez; Jacqueline N Minas; Jose Pablo Vazquez-Medina; Daisuke Nakano; David G Parkes; Akira Nishiyama; Rudy M Ortiz
Journal:  J Endocrinol       Date:  2018-04-11       Impact factor: 4.286

7.  Pioglitazone provides beneficial effect in metabolic syndrome rats via affecting intracellular Na+ Dyshomeostasis.

Authors:  Ayca Bilginoglu; Makbule Fulya Tutar Selcuk; Hilal Nakkas; Belma Turan
Journal:  J Bioenerg Biomembr       Date:  2018-10-25       Impact factor: 2.945

Review 8.  The (pro)renin receptor in health and disease.

Authors:  Atsuhiro Ichihara; Midori Sasaki Yatabe
Journal:  Nat Rev Nephrol       Date:  2019-11       Impact factor: 28.314

Review 9.  Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.

Authors:  Thomas Unger; Ludovit Paulis; Domenic A Sica
Journal:  Eur Heart J       Date:  2011-09-27       Impact factor: 29.983

Review 10.  The H+-ATPase (V-ATPase): from proton pump to signaling complex in health and disease.

Authors:  Amity F Eaton; Maria Merkulova; Dennis Brown
Journal:  Am J Physiol Cell Physiol       Date:  2020-12-16       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.